Computational mining of Enterococcus transcriptomes identified 14 candidate AMPs, with EM_4 showing potent activity (MIC 2.5-20 μM) against susceptible and XDR S. aureus and A. baumannii with low hemolysis.
2.5 μM MIC vs XDREM_4 kills extensively drug-resistant bacteria at very low concentrations with only 3.2% hemolysis
What the researchers found
EM_4: MIC 2.5-20 μM against susceptible and XDR S. aureus/A. baumannii; MBC 5-20 μM; antibiofilm 40-80 μM; 3.2% hemolysis; thermostable and salt-stable; membrane-disrupting mechanism.
Why it matters
XDR infections cause thousands of deaths with few treatment options. Mining commensal bacteria for AMPs exploits a co-evolutionary relationship between host and microbiome.
How the study worked
Transcriptome mining of Enterococcus species, computational AMP prediction and filtering, synthesis of EM_4, MIC/MBC, stability testing, antibiofilm assays, hemolysis, and DNA-release mechanism studies.
What this study cannot tell us
In vitro only. Single lead peptide validated. In vivo efficacy and toxicity not tested.
How to read the evidence
Well-executed computational-to-experimental pipeline with comprehensive in vitro validation. Novel AMP source.
When this study was published
Published in 2025.
The bigger picture
Probiotic bacteria have co-evolved antimicrobial defenses that could be harnessed as next-generation antibiotics against the most dangerous resistant pathogens.
Questions still open
- Would EM_4 be effective in animal XDR infection models?
- Could other Enterococcus-derived AMPs complement EM_4's spectrum?
- Is the low hemolysis maintained at therapeutic concentrations in vivo?
Common questions
Can gut bacteria provide new antibiotics?
Why is 3.2% hemolysis important?
Read the original research
Exploration of Novel Antimicrobial Peptides from Gut Probiotics Enterococcus spp. Against Extensively drug-resistant Pathogens Through cutting-edge Computational Discovery.
Probiotics and antimicrobial proteins
Citation
Hasannejad-Asl, Behnam; Bagheri, Kamran Pooshang; Bandehpour, Mojgan; Bolhassani, Azam; Hashemi, Ali; Pooresmaeil, Farkhondeh; Kazemi, Bahram. (2026). Exploration of Novel Antimicrobial Peptides from Gut Probiotics Enterococcus spp. Against Extensively drug-resistant Pathogens Through cutting-edge Computational Discovery.. Probiotics and antimicrobial proteins. https://doi.org/10.1007/s12602-026-10919-w